Proteomic evaluation of core biopsy specimens from breast lesions

被引:20
作者
Bisca, A
D'Ambrosio, C
Scaloni, A
Puglisi, F
Aprile, G
Piga, A
Zuiani, C
Bazzocchi, M
Di Loreto, C
Paron, I
Tell, G
Damante, G
机构
[1] Univ Udine, Ctr MATI, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy
[2] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy
[3] Policlin Univ Udine, Unita Studio Mammella, Udine, Italy
[4] Univ Udine, Dipartimento Ric Med & Morfol, I-33100 Udine, Italy
[5] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, CEB, I-34127 Trieste, Italy
关键词
proteomics; breast cancer; mass spectrometry;
D O I
10.1016/j.canlet.2003.09.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Analysis of tumour samples by a proteomic technology, which combines two-dimensional gel electrophoresis and mass spectrometry analysis, is a promising approach for molecular characterization of cancer. Proteomic analysis of neoplasms is usually performed on surgical material. The possibility to perform proteomic analysis on pre-operative samples might be useful for diagnostic purposes or for determination of tumour sensitivity to therapy. In this study, we report how tissues from core biopsy of breast lesions can be routinely used to obtain accurate protein expression profiles by proteomic analysis. Protein profiles from fibroadenomas were compared to those from ductal infiltrating carcinomas. By using mass spectrometry, identification of proteins overexpressed in carcinomas with respect to fibroadenomas was obtained. Thus, our study provides a methodology to perform proteomic analysis on pre-operative samples of breast lesions. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 27 条
  • [1] Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer
    Adam, PJ
    Boyd, R
    Tyson, KL
    Fletcher, GC
    Stamps, A
    Hudson, L
    Poyser, HR
    Redpath, N
    Griffiths, M
    Steers, G
    Harris, AL
    Patel, S
    Berry, J
    Loader, JA
    Townsend, RR
    Daviet, L
    Legrain, P
    Parekh, R
    Terrett, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 6482 - 6489
  • [2] Bertram John S., 2000, Molecular Aspects of Medicine, V21, P167, DOI 10.1016/S0098-2997(00)00007-8
  • [3] Protein expression profiles in human breast ductal carcinoma and histologically normal tissue
    Bini, L
    Magi, B
    Marzocchi, B
    Arcuri, F
    Tripodi, S
    Cintorino, M
    Sanchez, JC
    Frutiger, S
    Hughes, G
    Pallini, V
    Hochstrasser, DF
    Tosi, P
    [J]. ELECTROPHORESIS, 1997, 18 (15) : 2832 - 2841
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] Czerwenka KF, 2001, CANCER DETECT PREV, V25, P268
  • [6] Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins
    Franzen, B
    Linder, S
    Alaiya, AA
    Eriksson, E
    Uruy, K
    Hirano, T
    Okuzawa, K
    Auer, G
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (10) : 1632 - 1638
  • [7] Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system
    Gharbi, S
    Gaffney, P
    Yang, A
    Zvelebil, MJ
    Cramer, R
    Waterfield, MD
    Timms, JF
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (02) : 91 - 98
  • [8] Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
    Gygi, SP
    Rist, B
    Gerber, SA
    Turecek, F
    Gelb, MH
    Aebersold, R
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (10) : 994 - 999
  • [9] Fast-response proteomics by accelerated in-gel digestion of proteins
    Havlis, J
    Thomas, H
    Sebela, M
    Shevchenko, A
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (06) : 1300 - 1306
  • [10] HETEROGENEITY OF GLYCOLYTIC ENZYME-ACTIVITY AND ISOZYME COMPOSITION OF PYRUVATE-KINASE IN BREAST-CANCER
    HENNIPMAN, A
    VANOIRSCHOT, BA
    SMITS, J
    RIJKSEN, G
    STAAL, GEJ
    [J]. TUMOR BIOLOGY, 1988, 9 (04) : 178 - 189